Cancer Imaging is the official journal of the International Cancer Imaging Society (ICIS)
Articles
Page 16 of 18
-
Citation: Cancer Imaging 2014 14(Suppl 1):O40
-
Comprehensive breast MRI: an update
Citation: Cancer Imaging 2014 14(Suppl 1):O39 -
Lung, CNS and musculo-skeletal targeted therapy-induced toxicity: imaging features
Citation: Cancer Imaging 2014 14(Suppl 1):O38 -
Hybrid imaging with PET/CT and PET/MR
Citation: Cancer Imaging 2014 14(Suppl 1):O32 -
Cancer imaging in the era of precision treatment: present and future
Citation: Cancer Imaging 2014 14(Suppl 1):O30 -
Imaging neuroendocrine tumours of the pancreas: role of CT and MRI
Citation: Cancer Imaging 2014 14(Suppl 1):O28 -
Noncommunicating cystic pancreatic lesions (i.e. serous and mucinous cystadenoma + rare lesions)
Citation: Cancer Imaging 2014 14(Suppl 1):O27 -
Characterization and management of cystic pancreatic neoplasms communicating lesions (IPMN)
Citation: Cancer Imaging 2014 14(Suppl 1):O26 -
Session: Evaluation of lung nodules: role of PET/CT
Citation: Cancer Imaging 2014 14(Suppl 1):O25 -
Management of solid and sub-solid lung nodules
Citation: Cancer Imaging 2014 14(Suppl 1):O24 -
Whole-body DWI in patients with lymphoma: imaging findings, pitfalls, and limitations
Citation: Cancer Imaging 2014 14(Suppl 1):O22 -
Complications following locoregional therapy of renal cancer
Citation: Cancer Imaging 2014 14(Suppl 1):O21 -
Locoregional therapy of renal cancer
Citation: Cancer Imaging 2014 14(Suppl 1):O20 -
Ovarian cancer: imaging in treatment selection and planning with FIGO update
Citation: Cancer Imaging 2014 14(Suppl 1):O18 -
Pediatric tumours: liver tumours
Citation: Cancer Imaging 2014 14(Suppl 1):O16 -
Neuroblastoma and nephroblastoma: an overview and comparison
Citation: Cancer Imaging 2014 14(Suppl 1):O15 -
Clinical management of patients with complicated multifocal disease
Citation: Cancer Imaging 2014 14(Suppl 1):O11 -
Screening & staging of colorectal cancer
Citation: Cancer Imaging 2014 14(Suppl 1):O8 -
Staging of lung cancer CT and PET
Citation: Cancer Imaging 2014 14(Suppl 1):O6 -
MR imaging
Citation: Cancer Imaging 2014 14(Suppl 1):O5 -
Agreement of diameter- and volume-based pulmonary nodule management in CT lung cancer screening
Citation: Cancer Imaging 2014 14(Suppl 1):S4 -
Global challenges of cancer imaging: perspective from different parts of the world: Asia
Citation: Cancer Imaging 2014 14(Suppl 1):O3 -
Global challenges in oncologic imaging
Citation: Cancer Imaging 2014 14(Suppl 1):O1 -
Correlation between semiquantitative sonoelastography and immunohistochemistry in the evaluation of testicular focal lesions
Sonoelastography is a novel and promising imaging tool, which has been applied to breast, thyroid, and prostate tissues. The aim of this study was to evaluate focal lesions of the testes with diameters of <10 ...
Citation: Cancer Imaging 2014 14:29 -
Chest-abdomen-pelvis CT for staging in cancer patients: dose effectiveness and image quality using automated attenuation-based tube potential selection
Evaluation of automated attenuation-based tube potential selection and its impact on image quality and radiation dose in CT (computed tomography) examinations for cancer staging.
Citation: Cancer Imaging 2014 14:28 -
Endoscopic ultrasound – fine needle aspiration of 2-deoxy-2-[18F] fluoro-D-glucose avid lymph nodes seen on positron emission tomography- computed tomography –what looks like cancer may not always be so
Patients suffering from malignancies often undergo serial positron emission tomography - computed tomography (PET-CT) scans, using 2-deoxy-2-[18F] fluoro-D-glucose (FDG) for diagnosis and follow up. This principl...
Citation: Cancer Imaging 2014 14:27 -
New targeted molecular therapies for cancer: radiological response in intrathoracic malignancies and cardiopulmonary toxicity: what the radiologist needs to know
The emergence of new novel therapeutic agents which directly target molecules that are uniquely or abnormally expressed in cancer cells (molecular targeted therapy, MTT) has changed dramatically the treatment ...
Citation: Cancer Imaging 2014 14:26 -
The impact of 18 F-FET PET-CT on target definition in image-guided stereotactic radiotherapy in patients with skull base lesions
18 F-fluoro-ethyl-tyrosine PET is gaining more indications in the field of oncology. We investigated the potentials of usage of FET-PET/CT in addition to MRI for definition of gross tumor volume (GTV) in stere...
Citation: Cancer Imaging 2014 14:25 -
A prospective investigation into the clinical impact of 4D-PET/CT in the characterisation of solitary pulmonary nodules
While the effects of respiratory motion on measuring metabolic signal in PET/CT scanning are well known, it is still standard practice in most centres to scan patients while breathing freely with no correction...
Citation: Cancer Imaging 2014 14:24 -
Mediastinal staging in non-small-cell lung carcinoma: computed tomography versus F-18-fluorodeoxyglucose positron-emission tomography and computed tomography
After the diagnosis Non-Small-Cell Lung Carcinoma (NSCLC) has been established, consideration must turn toward the stage of disease, because this will impact directly on management and prognosis. Staging is used ...
Citation: Cancer Imaging 2014 14:23 -
MR imaging features of intracranial primary CNS lymphoma in immune competent patients
We aimed to characterize specific MRI findings seen in immune competent patients with intracranial primary CNS lymphoma (PCNSL) and to determine their value in the management of such patients. Pre-treatment MR...
Citation: Cancer Imaging 2014 14:22 -
Muscle metastases: comparison of features in different primary tumours
Muscle metastases (MM) from solid tumours are rare. The aim of this study was to describe radiological features of MM, and to compare their patterns in different malignancies.
Citation: Cancer Imaging 2014 14:21 -
The role of diffusion and perfusion weighted imaging in the differential diagnosis of cerebral tumors: a review and future perspectives
The role of conventional Magnetic Resonance Imaging (MRI) in the detection of cerebral tumors has been well established. However its excellent soft tissue visualization and variety of imaging sequences are in ...
Citation: Cancer Imaging 2014 14:20 -
Neoadjuvant intra-arterial chemotherapy in patients with primary lacrimal adenoid cystic carcinoma
We describe four cases of primary lacrimal adenoid cystic carcinoma (ACC) treated with neoadjuvant intra-arterial chemotherapy (NAIC).
Citation: Cancer Imaging 2014 14:19 -
Imaging acute complications in cancer patients: what should be evaluated in the emergency setting?
Increased incidence world-wide of cancer and increased survival has also resulted in physicians seeing more complications in patients with cancer. In many cases, complications are the first manifestations of t...
Citation: Cancer Imaging 2014 14:18 -
The evaluation of anti-angiogenic effects of Endostar on rabbit VX2 portal vein tumor thrombus using perfusion MSCT
There were many treatments for hepatocellular carcinoma with portal vein tumor thrombus (PVTT), in which targeted anti-angiogenic drug therapy is becoming a popular research topic. However, an objective and no...
Citation: Cancer Imaging 2014 14:17 -
Asymptomatic myocardial metastasis from cancers of upper aero-digestive tract detected on FDG PET/CT: a series of 4 cases
Metastatic involvement of the heart is a rare occurrence and remains undiagnosed until autopsy. In some instances, patients may have cardiac symptoms, leading to ante-mortem diagnosis. Although most primary ca...
Citation: Cancer Imaging 2014 14:16 -
Prognostic factors in advanced pharyngeal and oral cavity cancer; significance of multimodality imaging in terms of 7th edition of TNM
As with most cancers the prognosis in pharyngeal and oral cavity cancer largely depends on tumour stage. Physical examination, including endoscopy should be combined with technical radiologic imaging to record...
Citation: Cancer Imaging 2014 14:15 -
Imaging of malignancies of the biliary tract- an update
Malignancies of the biliary tract include cholangiocarcinoma, gallbladder cancers and carcinoma of the ampulla of Vater. Biliary tract adenocarcinomas are the second most common primary hepatobiliary cancer. D...
Citation: Cancer Imaging 2014 14:14 -
RECIST measurements in cancer treatment: is there a role for physician assistants? - A pilot study
Decision making in cancer treatment is influenced by standardized RECIST measurements which are subjective to interobserver variability. Aim of this pilot study was to evaluate whether it is feasible to transf...
Citation: Cancer Imaging 2014 14:12 -
Investigation of the optimal b-value to detect breast tumors with diffusion weighted imaging by 1.5-T MRI
Previous studies have reported that the signal attenuation of diffusion-weighted magnetic resonance imaging (DWI) for normal breast tissue and tumor were well fitted by a monoexponential and a biexponential fu...
Citation: Cancer Imaging 2014 14:11 -
Contrast-enhanced [18 F] fluorodeoxyglucose-positron emission tomography/computed tomography in clinical oncology: tumor-, site-, and question-based comparison with standard positron emission tomography/computed tomography
The present study aimed to evaluate the added value of contrast-enhanced computed tomography (ceCT) in comparison to standard, non-enhanced CT in the context of a combined positron emission tomography (PET)/CT...
Citation: Cancer Imaging 2014 14:10 -
Dynamic multidetector computed tomography findings of hepatocellular carcinoma of hepatitis B virus-positive and -negative patients
The objective of this study was to retrospectively investigate and compare multidetector computed tomography findings of hepatocellular carcinoma (HCC) in hepatitis B virus (HBV)-positive and -negative patients.
Citation: Cancer Imaging 2014 14:9 -
Prediction of poorly differentiated hepatocellular carcinoma using contrast computed tomography
Percutaneous radiofrequency ablation (RFA) is a well-established local treatment for small hepatocellular carcinoma (HCC). However, poor differentiation is a risk factor for tumor seeding or intrahepatic disse...
Citation: Cancer Imaging 2014 14:7 -
Clinical evaluation of semi-automatic landmark-based lesion tracking software for CT-scans
To evaluate a semi-automatic landmark-based lesion tracking software enabling navigation between RECIST lesions in baseline and follow-up CT-scans.
Citation: Cancer Imaging 2014 14:6 -
Imaging of pancreatic metastases from renal cell carcinoma
To describe the main imaging characteristics of pancreatic metastases from renal cell carcinoma (RCC) with particular attention to CT features, underlining possible criteria for a differential diagnosis.
Citation: Cancer Imaging 2014 14:5 -
Difficulty distinguishing benign notochordal cell tumor from chordoma further suggests a link between them
Much discussion about benign notochordal cell tissue in vertebrae has centered on the nature of its relationship, if any, to chordoma. Often referred to as benign notochordal cell tumors (BNCTs), these lesions...
Citation: Cancer Imaging 2014 14:4 -
Prediction of pathologic prognostic factors in patients with lung adenocarcinomas: comparison of thin-section computed tomography and positron emission tomography/computed tomography
The ratio of the maximum diameter of consolidation to the maximum tumor diameter (C/T ratio) on thin-section computed tomography (TSCT) and the maximum standardized uptake value (SUVmax) on 18 F-fluorodeoxyglucos...
Citation: Cancer Imaging 2014 14:3 -
Prognostic value of volumetric metabolic parameters measured by [18F]Fluorodeoxyglucose-positron emission tomography/computed tomography in patients with small cell lung cancer
We evaluated the prognostic value of volume-based metabolic positron emission tomography (PET) parameters in patients with small cell lung cancer (SCLC) compared with other factors.
Citation: Cancer Imaging 2014 14:2 -
Cancer imaging: Quo vadis?
Citation: Cancer Imaging 2014 14:1
Official journal of
Follow
Annual Journal Metrics
-
2022 Citation Impact
4.9 - 2-year Impact Factor
4.7 - 5-year Impact Factor
1.636 - SNIP (Source Normalized Impact per Paper)
1.231 - SJR (SCImago Journal Rank)2022 Speed
14 days submission to first editorial decision for all manuscripts (Median)
122 days submission to accept (Median)2022 Usage
798,074 downloads
454 Altmetric mentions